We showed that the TIMP-1 gene-deficient fibrosarcoma cells were considerably more sensitive to the chemotherapeutic drugs tested, compared to the corresponding TIMP-1 wild-type cells, confirming that TIMP-1 protects against chemotherapy in our model system. Here, TIMP1 is linked to fibrosarcoma.